AzTrials
AzTrials

StrokeIPASS-RNCT06588647

Improving Participation After Stroke Self-Management-Rehabilitation

A study testing Improving Participation after Stroke Self-Management Program (IPASS) and Chronic Disease Self-Management Program (CDSMP) in people with Stroke, run by University of Missouri-Columbia at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The overall goal of this proposed study is to evaluate the efficacy of a small-group, stroke-specific, self-management program delivered via telehealth to improve self-efficacy, activity performance, and quality of life in individuals with sub-acute stroke. Read more about this study

Who is it for?
Ages 45 to 85 years
Conditions the study is for
Stroke
What is being tested?
Improving Participation after Stroke Self-Management Program (IPASS) and Chronic Disease Self-Management Program (CDSMP)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited States
Study dates
16 Dec 2024to 15 Dec 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • less than 6 months post-stroke
  • age 45-85 years
  • completed inpatient rehabilitation services (if recommended)
  • living in the community with or without caregiver support (i.e., not living in a skilled nursing facility)
  • ability to read, write, and speak English
  • diagnosis of mild or moderate stroke (National Institutes of Health stroke score <16)
  • able to use videoconferencing independently or with caregiver support

Who cannot join

  • severe depressive symptoms as indicated by a score ≥21 on the Patient Health Questionnaire
  • dementia symptoms as indicated by a score of <23 on the Montreal Cognitive Assessment
  • additional neurological diagnoses (e.g., brain malignancy, previous severe stroke)
  • (4) moderate or severe aphasia as indicated by a National Institutes of Health Stroke Scale aphasia score of ≥ 2
  • inability to provide informed consent
  • any other condition not otherwise specified that the PI determines would render participation in this study as unsafe for the participant

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Anna E Boone, PhD, OTR/L contact

5738827023

booneae@umsystem.edu

Juliana H. Earwood, OTD, OTR/L contact

5738846681

jmhudson@health.missouri.edu

United States1 site, 1 recruiting
  • University of Missouri

    Columbia, Missouri, 65211

    Juliana Earwood, OTD, 573-884-6681, jmhudson@health.missouri.edu

    Anna Boone, PhD

    Recruiting

Other trials in United States

About this study

Official title: Efficacy of the Improving Participation After Stroke Self-Management-Rehabilitation (IPASS-R) Program in Sub-acute Stroke

The overall goal of this proposed study is to evaluate the efficacy of a small-group, stroke-specific, self-management program delivered via telehealth to improve self-efficacy, activity performance, and quality of life in individuals with sub-acute stroke.

Conditions
Stroke
Being tested
Improving Participation after Stroke Self-Management Program (IPASS), Chronic Disease Self-Management Program (CDSMP)
Keywords
Stroke, Self-Management, Telehealth, Activities of daily living, Community engagement
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Improving Participation after Stroke Self-Management Program (IPASS)Behavioural

    The IPASS-R program is a group-based self-management intervention that aims to improve problem-solving, action-planning, and resource utilization skills for improved community living and participation. The Activity-Barriers-Changes-Doing-Evaluation (ABCDE) framework is a user friendly problem-solving and goal setting framework that is used repetitively in each session throughout the program. Participants are guided to identify (1) an activity that they want to improve or re-engage in (A); (2) individual and environmental barriers that hinder their engagement (B); (3) changes that they can make to deal with the barriers and improve their engagement (C); and (4) an action plan to pursue (D). After the action plan, participants come back in the next session and evaluate their performance in following through on their plans (E).

  • Chronic Disease Self-Management Program (CDSMP)Behavioural

    The program is facilitated by two trained leaders in small groups in a community setting with individuals who have chronic health problems and will follow the CDSMP protocol. Participants receive education on various health-related topics applicable to a range of chronic conditions, share experiences, and support one another.

Study groups in NCT06588647
Study groupRoleWhat they receive
Improving Participation after Stroke Self-Management Program (IPASS)ExperimentalThe IPASS-R intervention consists of 6 weekly 90-minute sessions delivered by an occupational therapist and stroke survivor peer facilitator. All sessions will be delivered remotely via videoconferencing.
Receives: Behavioral: Improving Participation after Stroke Self-Management Program (IPASS)
Chronic Disease Self-Management Program (CDSMP)Active comparatorThe CDSMP will consist of 6, weekly 90-minute sessions. All sessions will be delivered remotely via videoconferencing.
Receives: Behavioral: Chronic Disease Self-Management Program (CDSMP)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Canadian Occupational Performance Measure (COPM) Performance

    Self-report measure of activity performance. Minimum = 1, Maximum = 10. Higher scores mean better performance.

    Measured: Pre-intervention (week 0), post-intervention (week 6), and 6-month follow-up (week 32)

  2. Canadian Occupational Performance Measure (COPM) Satisfaction

    Self-report measure of activity performance. Minimum = 1, Maximum = 10. Higher scores mean higher satisfaction.

    Measured: Pre-intervention (week 0), post-intervention (week 6), and 6-month follow-up (week 32)

  3. Participation Strategies Self-Efficacy Scale (PS-SES)

    Self-report measure of self-efficacy in using participation strategies. The subject rates confidence across 35 items within six subscales: (1) managing home participation, (2) staying organized, (3) planning and managing community participation, (4) managing work and productivity), (5) managing communication, and (6) advocating for resources. Range of scores from 35-350. Higher scores indicate greater self-efficacy.

    Measured: Pre-intervention (week 0), post-intervention (week 6), and 6-month follow-up (week 32)

Secondary outcomes (4)
  1. In home activity level as measured by sensor system

    average hourly percentage of time spent engaged in activity

    Measured: Duration of study (from baseline assessment (week 0) to 6-month follow-up assessment)

  2. Community engagement as measured by sensor system

    Time outside the home as measured by time between door sensor activations

    Measured: Duration of study (from baseline assessment (week 0) to 6-month follow-up assessment)

  3. Stroke Impact Scale participation domain

    Measures perceived stroke recovery/quality of life. Range of scores 0-100. Higher scores indicate higher performance.

    Measured: Pre-intervention (week 0), post-intervention (week 6), and 6-month follow-up (week 32)

  4. Assessment of Life Habits (LIFE-H)

    Measures self-reported participation in daily activities by measuring total score across 6 domains. Score range of 0 to 9 with higher scores indicating better performance.

    Measured: Pre-intervention (week 0), post-intervention (week 6), and 6-month follow-up (week 32)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2024
  2. Study start16 Dec 2024
  3. Primary completion15 Dec 2029 (estimated)
  4. Study completion15 Dec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06588647
Sponsor's protocol ID
2108606
Other IDs
1R01HD114732-01
Acronym
IPASS-R
Status last verified
Apr 2026
First submitted
6 Sep 2024
Last updated
28 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Jette DU, Latham NK, Smout RJ, Gassaway J, Slavin MD, Horn SD. Physical therapy interventions for patients with stroke in inpatient rehabilitation facilities. Phys Ther. 2005 Mar;85(3):238-48.

    PubMed 15733048
  • Sakakibara BM, Kim AJ, Eng JJ. A Systematic Review and Meta-Analysis on Self-Management for Improving Risk Factor Control in Stroke Patients. Int J Behav Med. 2017 Feb;24(1):42-53. doi: 10.1007/s12529-016-9582-7.

    PubMed 27469998
  • Fryer CE, Luker JA, McDonnell MN, Hillier SL. Self management programmes for quality of life in people with stroke. Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD010442. doi: 10.1002/14651858.CD010442.pub2.

    PubMed 27545611
  • Chen L, Chen Y, Chen X, Shen X, Wang Q, Sun C. Longitudinal Study of Effectiveness of a Patient-Centered Self-Management Empowerment Intervention During Predischarge Planning on Stroke Survivors. Worldviews Evid Based Nurs. 2018 Jun;15(3):197-205. doi: 10.1111/wvn.12295.

    PubMed 29878691
  • Cadilhac DA, Hoffmann S, Kilkenny M, Lindley R, Lalor E, Osborne RH, Batterbsy M. A phase II multicentered, single-blind, randomized, controlled trial of the stroke self-management program. Stroke. 2011 Jun;42(6):1673-9. doi: 10.1161/STROKEAHA.110.601997. Epub 2011 Apr 14.

    PubMed 21493910
  • Wolf TJ, Baum CM, Lee D, Hammel J. The Development of the Improving Participation after Stroke Self-Management Program (IPASS): An Exploratory Randomized Clinical Study. Top Stroke Rehabil. 2016 Aug;23(4):284-92. doi: 10.1080/10749357.2016.1155278. Epub 2016 Mar 16.

    PubMed 27077987
  • Lee D, Fischer H, Zera S, Robertson R, Hammel J. Examining a participation-focused stroke self-management intervention in a day rehabilitation setting: a quasi-experimental pilot study. Top Stroke Rehabil. 2017 Dec;24(8):601-607. doi: 10.1080/10749357.2017.1375222. Epub 2017 Sep 28.

    PubMed 28956721

Questions about this trial

What is this clinical trial studying?

A study testing Improving Participation after Stroke Self-Management Program (IPASS) and Chronic Disease Self-Management Program (CDSMP) in people with Stroke, run by University of Missouri-Columbia at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Anna E Boone, PhD, OTR/L (5738827023, booneae@umsystem.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Canadian Occupational Performance Measure (COPM) Performance (time frame: Pre-intervention (week 0), post-intervention (week 6), and 6-month follow-up (week 32)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06588647, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in